Poultry Vaccines Market Report 2026

Poultry Vaccines Market Overview

• Poultry Vaccines market size has reached to $1.94 billion in 2025 • Expected to grow to $3.04 billion in 2030 at a compound annual growth rate (CAGR) of 9.5% • Growth Driver: Rising Zoonotic Disease Threats Drive Surging Demand For Poultry Vaccines In Global Markets • Market Trend: Advancements In Poultry Vaccine Technology Through A Focus Genotype Evolution • North America was the largest region in 2025.

What Is Covered Under Poultry Vaccines Market?

The poultry vaccine is a vaccination used to treat preventive diseases in poultry animals. Poultry vaccine immunizations are commonly used to prevent and control contagious poultry illnesses. This is used in chicken production, which seeks to boost productivity by avoiding or limiting the occurrence of clinical disease at the farm level. The main types of poultry vaccines are porcine vaccines, poultry vaccine, livestock vaccine, companion animal vaccine, aquaculture vaccines, and others. The porcine vaccines is used as one of the type of vaccine in poultry vaccines market. An injector with high pressure that is used to immunize pigs. It disperses 0.1 to 0.5 milliliters of vaccination dosage is called as porcine vaccine. It is used in different disease such as avain influenza and infectious bronchitis, which require dosage form in liquid vaccine, freeze dried vaccine and duct. The technology involved are toxoid, live attenuated vaccines, recombinant vaccines, inactivated vaccines, which are applied in broiler, layer and breeder.

What Is The Poultry Vaccines Market Growth Forecast?

The poultry vaccines market size is expected to see strong growth in the next few years. It will grow to $3.04 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to growth of recombinant and dna vaccines, adoption of precision poultry vaccination programs, technological advancements in vaccine delivery systems, government initiatives for poultry health, increasing focus on biosecurity measures in poultry farms. Major trends in the forecast period include adoption of live and inactivated poultry vaccines, focus on disease prevention in broilers and layers, expansion of recombinant and dna vaccine usage, integration of vaccination programs with farm management practices, development of cold chain infrastructure for poultry vaccine distribution.

Global Poultry Vaccines Market Segmentation

1) By Type: Porcine Vaccines, Poultry Vaccine, Livestock Vaccine, Companion Animal Vaccine, Aquaculture Vaccines, Other Animal Vaccines 2) By Disease Type: Avain Influenza, Infectious Bronchitis 3) By Dosage Form: Liquid Vaccine, Freeze Dried Vaccine, Duct 4) By Technology: Toxoid, Live Attenuated Vaccines, Recombinant Vaccines, Inactivated Vaccines 5) By Application: Broiler, Layer, Breeder Subsegments: 1) By Porcine Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, DNA Vaccines, Recombinant Vaccines, Toxoid Vaccines 2) By Poultry Vaccines: Live Vaccines, Inactivated Vaccines, Recombinant Vaccines, Subunit Vaccines, DNA Vaccines 3) By Livestock Vaccines: Bovine Vaccines, Swine Vaccines, Ovine Vaccines 4) By Companion Animal Vaccines: Canine Vaccines, Feline Vaccines, Ferret Vaccines 5) By Aquaculture Vaccines: Fish Vaccines, Shrimp Vaccines 6) By Other Animal Vaccines: Wildlife Vaccines, Exotic Animal Vaccines

What Is The Driver Of The Poultry Vaccines Market?

The increasing prevalence of zoonotic diseases is expected to propel the growth of the poultry vaccine market going forward. Zoonotic diseases are a group of common diseases caused by pathogenic germs such as viruses, bacteria, parasites, and fungi. The increasing prevalence of zoonotic diseases is rising due to increased human–animal interaction, as expanding urbanization and livestock farming bring people and animals into closer contact. The poultry vaccine market supports the increasing prevalence of zoonotic diseases, as rising disease risks drive the need for vaccination to prevent the spread of infections from poultry to humans and ensure flock health. For instance, in December 2025, according to European Centre for Disease Prevention and Control, a Sweden-based government agency, in 2024, the five most reported zoonoses in humans were campylobacteriosis, with 168,396 cases (55.3 cases per 100,000 people), salmonellosis, with 79,703 cases (18.6 cases per 100,000 people), Shiga toxin-producing Escherichia coli (STEC) infections, with 11,738 cases (3.5 cases per 100,000 people) and echinococcosis, with 984 cases (0.22 cases per 100,000 people). Therefore, the increasing prevalence of zoonotic diseases is expected to drive the growth of poultry vaccines.

Key Players In The Global Poultry Vaccines Market

Major companies operating in the poultry vaccines market are Merck & Co Inc., Boehringer Ingelheim International GmbH, Zoetis Inc., Ringpu Biology, MSD Animal Health, Elanco Animal Health Incorporated, Ceva Santé Animale S.A., Phibro Animal Health Corporation, Huvepharma AD, Venkys India Limited, Vetoquinol S.A., Indian Immunologicals Limited, Vaccination Services Pvt Ltd., Indovax Private Limited, Bio-Vet Inc., Hester Biosciences Limited, Intervet Inc., Anicon Labor GmbH, CZ Veterinaria S.A., Bioproperties Pty Ltd, Bioveta a.s., Aptimmune Biologics Inc., HIPRA S.A., Biovac (Pty) Ltd., Nisseiken Co Ltd., Zydus Animal Health Limited, Jinyu Bio-Technology Co Ltd., Kyoto Biken Laboratories Inc.

Global Poultry Vaccines Market Trends and Insights

Major companies operating in the poultry vaccine market are focused on developing new technological solutions to strengthen their position. New technological solutions refer to advanced vaccine formulations, delivery systems, and diagnostic tools designed to enhance disease prevention, efficacy, and poultry health management. For instance, in October 2023, Zoetis Inc., a US-based animal health company launched Circomax. The porcine circovirus type 2 (PCV2) vaccine comes in two genotypes a and b. The goal of the vaccination is to defend against PCV2 risks, such as the three genotypes seen in the UK pig herd, and to offer broader coverage. The only PCV2 vaccination that is licensed to protect against all three genotypes is this one, which has shown protection against PCV2a, PCV2b, and PCV2d. With the introduction of CircoMax, Zoetis is attempting to keep ahead of the PCV2 genotype evolution and offer healthy piglets high levels of efficacy, convenience, and proven safety.

What Are Latest Mergers And Acquisitions In The Poultry Vaccines Market?

In July 2025, Vaxxinova NV, a Netherlands‑based animal health company providing vaccines and immunization solutions for livestock and poultry, acquired Deltamune (Pty) Ltd for an undisclosed amount. With this acquisition, Vaxxinova aims to strengthen and expand its vaccine research, development and production capabilities in the African livestock market while broadening its global footprint and portfolio of animal health solutions. Deltamune (Pty) Ltd is a South Africa‑based animal health company specializing in the development, manufacture and distribution of licensed and autogenous vaccines and healthcare products for livestock, serving markets across Sub‑Saharan Africa.

Regional Outlook

North America was the largest region in the poultry vaccines market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Poultry Vaccines Market?

The poultry vaccine market consists of revenues earned by entities by providing poultry vaccine services such as poultry health management, vaccination to poultry ducks, vaccination knowledge management, trainings. The market value includes the value of related goods sold by the service provider or included within the service offering. The poultry vaccine market also includes sales of chicken farm equipment, vaccination syringe, drugs, needle gun which are used in providing poultry vaccine services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.